CONSOLIDATED STATEMENTS OF CASH FLOW (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Operating Activities
Net income	$ 17,787	$ 10,014
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	14,600	29,250
Depreciation expense	3,792	3,999
Securities amortization, net	1,794	1,057
Stock based compensation expense	252	86
Amortization of purchased intangible assets	1,477	1,550
Increase in cash surrender value of life insurance policies	(903)	(902)
Gain on life insurance benefit	(141)	(67)
Securities gains	(4,917)	(2,978)
Net ORE loss and write-downs	1,212	611
Gain on loans sold	(2,386)	(3,139)
Loans originated for sale	(120,413)	(175,078)
Proceeds from loan sales	122,101	176,406
Change in other assets and liabilities	4,975	5,705
Net cash provided by operating activities	39,230	46,514
Investing Activities
Purchases of securities available for sale	(285,169)	(300,838)
Proceeds from calls, maturities, and payments on securities available for sale	90,330	109,294
Proceeds from sales of securities available for sale	161,744	111,564
Proceeds from life insurance benefit	893	124
Proceeds from ORE sales	11,918	6,818
Loan originations and payments, net	81,749	119,958
Purchases of premises and equipment	(5,494)	(4,158)
Proceeds from redemption of restricted stock	2,394	5,825
Net cash provided by investing activities	58,365	48,587
Financing Activities
Net change in deposits	(43,817)	(18,021)
Net change in other borrowings	(7,855)	(19,134)
Proceeds from FHLB advances	15,000
Repayment of FHLB advances	(15,568)	(42,093)
Cash dividends on preferred stock	(2,138)	(2,137)
Cash dividends on common stock	(605)	(604)
Net cash (used) by financing activities	(54,983)	(81,989)
Net change in cash and cash equivalents	42,612	13,112
Cash and cash equivalents, beginning of year	60,123	71,689
Cash and cash equivalents, end of period	$ 102,735	$ 84,801